424 related articles for article (PubMed ID: 29284197)
1. The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys.
Degenhardt L; Saha S; Lim CCW; Aguilar-Gaxiola S; Al-Hamzawi A; Alonso J; Andrade LH; Bromet EJ; Bruffaerts R; Caldas-de-Almeida JM; de Girolamo G; Florescu S; Gureje O; Haro JM; Karam EG; Karam G; Kovess-Masfety V; Lee S; Lepine JP; Makanjuola V; Medina-Mora ME; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Sampson NA; Scott KM; Stagnaro JC; Ten Have M; Kendler KS; Kessler RC; McGrath JJ;
Addiction; 2018 May; 113(5):924-934. PubMed ID: 29284197
[TBL] [Abstract][Full Text] [Related]
2. Association Between Psychotic Experiences and Subsequent Suicidal Thoughts and Behaviors: A Cross-National Analysis From the World Health Organization World Mental Health Surveys.
Bromet EJ; Nock MK; Saha S; Lim CCW; Aguilar-Gaxiola S; Al-Hamzawi A; Alonso J; Borges G; Bruffaerts R; Degenhardt L; de Girolamo G; de Jonge P; Florescu S; Gureje O; Haro JM; He Y; Hu C; Karam EG; Kovess-Masfety V; Lee S; Lepine JP; Mneimneh Z; Navarro-Mateu F; Ojagbemi A; Posada-Villa J; Sampson NA; Scott KM; Stagnaro JC; Viana MC; Xavier M; Kessler RC; McGrath JJ;
JAMA Psychiatry; 2017 Nov; 74(11):1136-1144. PubMed ID: 28854302
[TBL] [Abstract][Full Text] [Related]
3. Psychotic experiences and general medical conditions: a cross-national analysis based on 28 002 respondents from 16 countries in the WHO World Mental Health Surveys.
Scott KM; Saha S; Lim CCW; Aguilar-Gaxiola S; Al-Hamzawi A; Alonso J; Benjet C; Bromet EJ; Bruffaerts R; Caldas-de-Almeida JM; de Girolamo G; de Jonge P; Degenhardt L; Florescu S; Gureje O; Haro JM; Hu C; Karam EG; Kovess-Masfety V; Lee S; Lepine JP; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Sampson NA; Stagnaro JC; Kessler RC; McGrath JJ
Psychol Med; 2018 Dec; 48(16):2730-2739. PubMed ID: 29478433
[TBL] [Abstract][Full Text] [Related]
4. The association between childhood adversities and subsequent first onset of psychotic experiences: a cross-national analysis of 23 998 respondents from 17 countries.
McGrath JJ; McLaughlin KA; Saha S; Aguilar-Gaxiola S; Al-Hamzawi A; Alonso J; Bruffaerts R; de Girolamo G; de Jonge P; Esan O; Florescu S; Gureje O; Haro JM; Hu C; Karam EG; Kovess-Masfety V; Lee S; Lepine JP; Lim CC; Medina-Mora ME; Mneimneh Z; Pennell BE; Piazza M; Posada-Villa J; Sampson N; Viana MC; Xavier M; Bromet EJ; Kendler KS; Kessler RC
Psychol Med; 2017 May; 47(7):1230-1245. PubMed ID: 28065209
[TBL] [Abstract][Full Text] [Related]
5. Psychotic Experiences in the General Population: A Cross-National Analysis Based on 31,261 Respondents From 18 Countries.
McGrath JJ; Saha S; Al-Hamzawi A; Alonso J; Bromet EJ; Bruffaerts R; Caldas-de-Almeida JM; Chiu WT; de Jonge P; Fayyad J; Florescu S; Gureje O; Haro JM; Hu C; Kovess-Masfety V; Lepine JP; Lim CC; Mora ME; Navarro-Mateu F; Ochoa S; Sampson N; Scott K; Viana MC; Kessler RC
JAMA Psychiatry; 2015 Jul; 72(7):697-705. PubMed ID: 26018466
[TBL] [Abstract][Full Text] [Related]
6. Association of Cohort and Individual Substance Use With Risk of Transitioning to Drug Use, Drug Use Disorder, and Remission From Disorder: Findings From the World Mental Health Surveys.
Degenhardt L; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Andrade LH; Bunting B; Cia A; de Girolamo G; De Jonge P; Demyttenaere K; Gureje O; Haro JM; Harris MG; He Y; Hinkov H; Karam AN; Karam EG; Kiejna A; Kovess-Masfety V; Lasebikan V; Lee S; Levinson D; Medina-Mora ME; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Scott K; Stein DJ; Tachimori H; Tintle N; Torres Y; Kessler RC;
JAMA Psychiatry; 2019 Jul; 76(7):708-720. PubMed ID: 30865282
[TBL] [Abstract][Full Text] [Related]
7. The Bidirectional Associations Between Psychotic Experiences and DSM-IV Mental Disorders.
McGrath JJ; Saha S; Al-Hamzawi A; Andrade L; Benjet C; Bromet EJ; Browne MO; Caldas de Almeida JM; Chiu WT; Demyttenaere K; Fayyad J; Florescu S; de Girolamo G; Gureje O; Haro JM; Ten Have M; Hu C; Kovess-Masfety V; Lim CC; Navarro-Mateu F; Sampson N; Posada-Villa J; Kendler KS; Kessler RC
Am J Psychiatry; 2016 Oct; 173(10):997-1006. PubMed ID: 26988628
[TBL] [Abstract][Full Text] [Related]
8. Rural birth/upbringing and childhood adversities are associated with psychotic experiences in university students in China.
Wang C; Wang Q; Li X; Zhang Y; Wei W; Deng W; Guo W; He L; Tang W; Chen T; Li T
Schizophr Res; 2019 Jul; 209():105-112. PubMed ID: 31101515
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of psychotic symptoms in substance users: a comparison across substances.
Smith MJ; Thirthalli J; Abdallah AB; Murray RM; Cottler LB
Compr Psychiatry; 2009; 50(3):245-50. PubMed ID: 19374969
[TBL] [Abstract][Full Text] [Related]
10. Predictors of comorbid polysubstance use and mental health disorders in young adults-a latent class analysis.
Salom CL; Betts KS; Williams GM; Najman JM; Alati R
Addiction; 2016 Jan; 111(1):156-64. PubMed ID: 26190689
[TBL] [Abstract][Full Text] [Related]
11. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L;
Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879
[TBL] [Abstract][Full Text] [Related]
12. Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates.
McCabe SE; West BT; Strobbe S; Boyd CJ
J Subst Abuse Treat; 2018 Oct; 93():38-48. PubMed ID: 30126540
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of adolescent psychotic experiences and later development of substance use disorder and suicidal behavior.
Cederlöf M; Kuja-Halkola R; Larsson H; Sjölander A; Östberg P; Lundström S; Kelleher I; Lichtenstein P
Schizophr Res; 2017 Mar; 181():13-16. PubMed ID: 27615409
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey.
Roberts RE; Roberts CR; Xing Y
Drug Alcohol Depend; 2007 Apr; 88 Suppl 1(Suppl 1):S4-13. PubMed ID: 17275212
[TBL] [Abstract][Full Text] [Related]
15. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
Hayley AC; Stough C; Downey LA
Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
[TBL] [Abstract][Full Text] [Related]
16. Childhood and adolescent psychotic experiences and risk of mental disorder: a systematic review and meta-analysis.
Healy C; Brannigan R; Dooley N; Coughlan H; Clarke M; Kelleher I; Cannon M
Psychol Med; 2019 Jul; 49(10):1589-1599. PubMed ID: 31088578
[TBL] [Abstract][Full Text] [Related]
17. Perceived discrimination and psychotic experiences in the English general population.
Stickley A; Oh H; Sumiyoshi T; Narita Z; DeVylder JE; Jacob L; Waldman K; Koyanagi A
Eur Psychiatry; 2019 Oct; 62():50-57. PubMed ID: 31527013
[TBL] [Abstract][Full Text] [Related]
18. Risk for Substance Use Disorders in young adulthood: Associations with developmental experiences of homelessness, foster care, and adverse childhood experiences.
Moss HB; Ge S; Trager E; Saavedra M; Yau M; Ijeaku I; Deas D
Compr Psychiatry; 2020 Jul; 100():152175. PubMed ID: 32345436
[TBL] [Abstract][Full Text] [Related]
19. Age of Onset and Lifetime Projected Risk of Psychotic Experiences: Cross-National Data From the World Mental Health Survey.
McGrath JJ; Saha S; Al-Hamzawi AO; Alonso J; Andrade L; Borges G; Bromet EJ; Oakley Browne M; Bruffaerts R; Caldas de Almeida JM; Fayyad J; Florescu S; de Girolamo G; Gureje O; Hu C; de Jonge P; Kovess-Masfety V; Lepine JP; Lim CC; Navarro-Mateu F; Piazza M; Sampson N; Posada-Villa J; Kendler KS; Kessler RC
Schizophr Bull; 2016 Jul; 42(4):933-41. PubMed ID: 27038468
[TBL] [Abstract][Full Text] [Related]
20. Substance use and sociodemographic background as risk factors for lifetime psychotic experiences in a non-clinical sample.
Rognli EB; Bramness JG; Skurtveit S; Bukten A
J Subst Abuse Treat; 2017 Mar; 74():42-47. PubMed ID: 28132699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
